WASHINGTON, July 14 -- Health Resources & Services Administration has issued a notice called: Request for Information, Training and Care Delivery Models for Safe Administration of Potential FDA-Approved Psychedelic Therapies in Ambulatory Clinical Settings.
The notice was published in the Federal Register on July 14 by Ann M. Sheehy, Principal Deputy Administrator.
Summary: On April 18, 2026, President Trump issued Executive Order (E.O.) 14401, "Accelerating Medical Treatments for Serious Mental Illness", acknowledging that individuals suffering from serious mental illness may not always respond to existing therapies. This request for information (RFI) solicits stakeholder feedback on training and care delivery models that could be used t...